United States v. Johnson

71 F. App'x 406
Procedural entryThis page is a short order in United States v. Johnson. Read the opinion of the Court — 246 F.3d 749
Court of Appeals for the Fifth Circuit·Decided August 19, 2003·No. 02-31082·Unpublished

Opinion

PER CURIAM. *

Brian Johnson pleaded guilty, pursuant to a written plea agreement, to one charge of conspiracy to possess ecstasy with intent to distribute. The district court sentenced him to 188 months in prison and a three-year term of supervised release. Johnson now appeals the district court’s judgment.

In the sole issue he raises on appeal, Johnson argues that trial counsel rendered ineffective assistance by allowing Johnson to sign the factual basis that accompanied his plea agreement. Johnson acknowledged in the factual basis that he was involved with cocaine hydrochloride, but Johnson asserts that he was not involved with this drug.

As a general rule, this court declines to review claims of ineffective assistance of counsel on direct appeal, although we may do so in exceptional cases. See United States v. Higdon, 882 F.2d 812, 314 (5th Cir.1987); United States v. Gibson, 55 F.3d 173, 179 (5th Cir.1995); see also Massaro v. United States, — U.S. -, 123 S.Ct. 1690, 155 L.Ed.2d 714 (2003). This is not the exceptional case. Accordingly, we decline to review Johnson’s ineffective-assistance claim in this direct appeal. The judgment of the district court is AFFIRMED.

*

Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Johnson, 71 F. App'x 406 (5th Cir. 2003).

71 F. App'x 406 (United States v. Johnson) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Gibson
55 F.3d 173 (Fifth Circuit, 1995)
Massaro v. United States
538 U.S. 500 (Supreme Court, 2003)
Ortho Pharmaceutical Corporation v. Amgen, Inc.
882 F.2d 806 (Third Circuit, 1989)